Product Details for ANDA 074629
IOPAMIDOL (IOPAMIDOL)
41%
Marketing Status: Discontinued
51%
Marketing Status: Discontinued
61%
Marketing Status: Discontinued
76%
Marketing Status: Discontinued
41%
Marketing Status: Discontinued
Active Ingredient: IOPAMIDOL
Proprietary Name: IOPAMIDOL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 41%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074629
Product Number: 001
Approval Date: Nov 6, 1996
Applicant Holder Full Name: BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE
Marketing Status: Discontinued
Patent and Exclusivity Information
IOPAMIDOL (IOPAMIDOL)
Proprietary Name: IOPAMIDOL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 41%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074629
Product Number: 001
Approval Date: Nov 6, 1996
Applicant Holder Full Name: BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE
Marketing Status: Discontinued
Patent and Exclusivity Information
51%
Marketing Status: Discontinued
Active Ingredient: IOPAMIDOL
Proprietary Name: IOPAMIDOL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 51%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074629
Product Number: 004
Approval Date: Mar 31, 1998
Applicant Holder Full Name: BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE
Marketing Status: Discontinued
Patent and Exclusivity Information
IOPAMIDOL (IOPAMIDOL)
Proprietary Name: IOPAMIDOL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 51%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074629
Product Number: 004
Approval Date: Mar 31, 1998
Applicant Holder Full Name: BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE
Marketing Status: Discontinued
Patent and Exclusivity Information
61%
Marketing Status: Discontinued
Active Ingredient: IOPAMIDOL
Proprietary Name: IOPAMIDOL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 61%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074629
Product Number: 002
Approval Date: Nov 6, 1996
Applicant Holder Full Name: BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE
Marketing Status: Discontinued
Patent and Exclusivity Information
IOPAMIDOL (IOPAMIDOL)
Proprietary Name: IOPAMIDOL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 61%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074629
Product Number: 002
Approval Date: Nov 6, 1996
Applicant Holder Full Name: BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE
Marketing Status: Discontinued
Patent and Exclusivity Information
76%
Marketing Status: Discontinued
Active Ingredient: IOPAMIDOL
Proprietary Name: IOPAMIDOL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 76%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074629
Product Number: 003
Approval Date: Nov 6, 1996
Applicant Holder Full Name: BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: IOPAMIDOL
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 76%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A074629
Product Number: 003
Approval Date: Nov 6, 1996
Applicant Holder Full Name: BAXTER HEALTHCARE CORP ANESTHESIA AND CRITICAL CARE
Marketing Status: Discontinued
Patent and Exclusivity Information